reviewNature Reviews Drug DiscoveryJul 15, 2020BRONZE OA

Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target

LMLauren MifflinDODimitry OfengeimJYJunying Yuan

Harvard University · Sanofi (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

483
total citations
FWCI
19.00
Percentile
100%
References
221
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • RIPK1
  • Kinase
  • Inflammation
  • Protein kinase A
  • Biology
  • Cell biology
  • Cancer research
  • Programmed cell death
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding